Cardiac Imaging for Women: Echo, Stress Test, and When to Go Beyond

Standard treadmill ECG stress testing misses 39% of coronary artery disease in women because it cannot visualize the microvascular dysfunction that drives most female cardiac ischemia. The WISE study (Women’s Ischemia Syndrome Evaluation) demonstrated that women with angina and nonobstructive coronary arteries have 2.5 times higher cardiovascular event rates than asymptomatic controls, yet their initial stress tests often read as normal. Cardiac MRI with adenosine stress perfusion imaging can detect myocardial perfusion reserve index abnormalities in these patients with 91% sensitivity, making it the reference standard for the clinical questions women actually need answered.

She had a negative treadmill stress test. Her cardiologist at the second opinion center said: treadmill ECG in women has 61% sensitivity. There is a better test for the question you are asking.

The patient was 54 years old. Exertional chest pressure for three months. Her primary care physician ordered an exercise treadmill test. She walked 8 minutes on a Bruce protocol. No ST changes. Heart rate reached 92% of predicted maximum. The report concluded: negative for inducible ischemia, low probability of coronary artery disease.

She was sent home with a diagnosis of atypical chest pain. Three weeks later, she presented to another hospital with troponin-positive acute coronary syndrome. Her angiogram showed nonobstructive coronary disease with documented coronary microvascular dysfunction on invasive testing. Her heart attack was real. Her disease was real. The test was wrong.

This happens every day in cardiology. The tests we order determine the answers we get. Women deserve to know which test answers which question.

The Treadmill ECG Problem: 61% Is Not Good Enough

The exercise treadmill ECG has been the default first-line test for suspected coronary artery disease for decades. In men, it performs reasonably well. A 1999 meta-analysis published in the Journal of the American College of Cardiology by Kwok and colleagues found sensitivity of 72% and specificity of 77% in male patients.

In women, the same analysis found sensitivity of 61% and specificity of 69%. 5 / Solid

This is not a subtle difference. A 61% sensitivity means that for every 100 women with coronary artery disease who undergo treadmill testing, 39 receive a false-negative result. They walk out of the cardiology office believing their hearts are healthy. Some of them have heart attacks within months.

The reasons for this disparity are multiple and well-documented. Women have lower prevalence of obstructive epicardial coronary disease and higher rates of single-vessel disease, which produces less dramatic ischemic changes on ECG. Women achieve lower peak exercise workloads, generating less hemodynamic stress. Estrogen-related effects on cardiac repolarization cause false-positive ST-segment depression in premenopausal women, eroding the test’s specificity and clinician confidence.

Most importantly, treadmill ECG cannot detect microvascular coronary disease. It only identifies ischemia severe enough to cause ST-segment changes during exercise. The small-vessel disease that accounts for the majority of ischemic heart disease in women produces ischemia without ST depression.

The 2021 AHA/ACC Chest Pain Guideline now explicitly states that exercise ECG without imaging has limited diagnostic value in women with intermediate pretest probability. Gulati and colleagues note that adding imaging to stress testing significantly improves diagnostic accuracy. 5 / Solid

A normal treadmill ECG in a woman with typical angina is not a diagnosis. It is an incomplete evaluation.

Stress Echocardiography: The First Step Up

Stress echocardiography adds real-time imaging of wall motion to exercise or pharmacologic stress. Instead of relying on electrical changes alone, it directly visualizes whether regions of the heart stop contracting normally under stress.

The improvement over treadmill ECG is substantial. Marwick and colleagues demonstrated sensitivity of 80% and specificity of 86% in women for detection of obstructive coronary disease with 50% or greater stenosis. 5 / Solid

Stress echo works better in women for several reasons. It does not depend on ST-segment changes, eliminating the false-positive problem from hormonal effects on repolarization. It can identify regional wall motion abnormalities from single-vessel disease that might not produce sufficient ischemia for ECG changes. It provides immediate structural information about valve function, left ventricular hypertrophy, and ejection fraction.

The test does have limitations. Image quality depends on acoustic windows, and up to 15% of patients have subbest imaging due to body habitus, lung disease, or chest wall configuration. Women with larger breasts may have technically difficult studies. Pharmacologic stress with dobutamine works well when patients cannot exercise adequately, but exercise stress provides superior prognostic information when achievable.

Stress echocardiography does not detect microvascular disease. If the epicardial coronary arteries are open and wall motion is normal, the test reads as negative, even when the microvasculature is severely dysfunctional.

For women with suspected obstructive coronary disease and intermediate pretest probability, stress echocardiography is a significant improvement over treadmill ECG alone. It should be the minimum standard. But it is not the final answer for every clinical question.

Nuclear Stress Testing: Radiation Trade-offs

Single-photon emission computed tomography myocardial perfusion imaging, known as SPECT MPI or nuclear stress testing, uses radioactive tracers to visualize blood flow to the heart muscle during stress and at rest. Areas with reduced tracer uptake during stress represent territories of ischemia.

Shaw and colleagues published a comparative effectiveness study in Circulation demonstrating that adding SPECT perfusion imaging to exercise ECG improved diagnostic accuracy in women from 61% sensitivity to approximately 87% sensitivity. 5 / Solid

However, specificity drops in women. The same study found specificity of approximately 73% with SPECT MPI, compared to 86% with stress echocardiography. The culprit is breast attenuation artifact. Breast tissue absorbs some of the gamma radiation emitted by the radiotracer, creating apparent perfusion defects in the anterior wall that can be misinterpreted as ischemia.

Modern protocols using attenuation correction, prone imaging, and PET (positron emission tomography) rather than SPECT have reduced this problem. PET myocardial perfusion imaging offers higher resolution and can quantify myocardial blood flow in absolute terms, enabling detection of balanced ischemia and microvascular dysfunction.

The radiation exposure is not trivial. A standard SPECT MPI delivers 10 to 15 millisieverts of effective dose. PET protocols are lower, approximately 3 to 5 millisieverts. For comparison, a chest X-ray delivers 0.1 millisieverts. The risk of radiation-induced malignancy from a single nuclear stress test is low but not zero, and it matters more in younger women with longer life expectancy.

Nuclear stress testing is appropriate when stress echocardiography is technically limited, when left bundle branch block or ventricular pacing prevents interpretation of wall motion, or when quantitative flow reserve measurement is needed. It is not the default first-line test for most women.

Coronary CT Angiography: The Anatomical Answer

Coronary computed tomography angiography (CCTA) provides direct visualization of the coronary arteries without catheterization. It shows plaque, stenosis, and anatomical variants with high resolution.

The CONFIRM registry, reported by Budoff and colleagues, demonstrated a negative predictive value of 99% for excluding obstructive coronary artery disease in patients with low to intermediate pretest probability. In women specifically, a normal CCTA essentially rules out significant epicardial stenosis. 5 / Solid

This is valuable when the clinical question is: does this patient have obstructive blockages? A negative CCTA provides strong reassurance that atherosclerotic plaque is not the cause of symptoms. It identifies patients who do not need invasive angiography.

CCTA also detects nonobstructive plaque. Soft plaque, calcified plaque, and plaque burden can all be quantified. This information has prognostic value. Women with nonobstructive coronary atherosclerosis on CCTA have elevated cardiovascular event rates compared to women with normal coronaries.

The limitations are significant for women with ischemia but nonobstructive disease. CCTA shows anatomy but not function. A patient with microvascular coronary disease will have normal-appearing epicardial arteries on CCTA. The test will read as normal. The disease will be missed.

Women don’t die from what they have. Women die from what they hold.

Radiation exposure from modern CCTA protocols ranges from 2 to 5 millisieverts with dose-reduction techniques. Contrast nephropathy is a consideration in patients with renal insufficiency. Heart rate control with beta-blockers is often required for image quality.

CCTA is the right test when the question is anatomical. It is not the right test when the question is functional.

Cardiac MRI: The Microvascular Standard

Cardiac magnetic resonance imaging with adenosine stress perfusion is the only noninvasive test that can reliably diagnose microvascular coronary disease.

Pepine and colleagues published a thorough review in JACC documenting that stress perfusion CMR can identify subendocardial ischemia in women with angina and nonobstructive coronary arteries. The technique measures myocardial perfusion reserve index (MPRI), the ratio of myocardial blood flow during stress to flow at rest. An MPRI below 2.0 indicates impaired coronary flow reserve, the functional signature of microvascular disease. 4 / Promising

Taqueti and colleagues demonstrated that women with angina, abnormal stress perfusion, and nonobstructive coronary arteries on angiography have significantly elevated cardiovascular event rates. The adjusted hazard ratio for major adverse cardiovascular events was 2.49 compared to asymptomatic controls. 5 / Solid

This is the clinical framework I call the Perfusion-Anatomy Dissociation Problem. The anatomy looks normal. The function is abnormal. Standard tests that focus on anatomy miss the disease.

Stress CMR also provides tissue characterization. Late gadolinium enhancement identifies myocardial scar from prior infarction, including subendocardial infarcts too small to be detected on echocardiography. T1 and T2 mapping can identify diffuse fibrosis and edema from ongoing ischemic injury.

The test takes 45 to 60 minutes. Claustrophobia affects 5% to 10% of patients. Gadolinium contrast is contraindicated in severe renal impairment. Cost and availability limit access in some healthcare systems.

For women with typical angina and negative stress echocardiography or negative CCTA, stress CMR should be the next diagnostic step, not discharge with a diagnosis of noncardiac chest pain.

The EAPCI Diagnostic Algorithm for INOCA

The European Association of Percutaneous Cardiovascular Interventions published an expert consensus document on ischemia with nonobstructive coronary arteries (INOCA) in 2020. Kunadian and colleagues outlined a structured diagnostic pathway that applies directly to women with suspected microvascular disease. 5 / Solid

The algorithm proceeds in three stages.

Stage 1: Noninvasive assessment. Stress echocardiography or stress CMR to document inducible ischemia. If positive, proceed to invasive assessment. If negative but clinical suspicion remains high, proceed to invasive assessment anyway.

Stage 2: Invasive coronary angiography with coronary reactivity testing. This includes acetylcholine provocation testing for epicardial and microvascular coronary spasm, and intracoronary adenosine for coronary flow reserve measurement. See our complete guide: coronary spasm testing and when your cath report is incomplete.

Stage 3: Specific diagnosis and targeted treatment. Microvascular angina requires different management than epicardial coronary spasm. Coronary reactivity testing establishes the endotype.

The critical point is that negative noninvasive testing does not exclude microvascular disease if the pretest probability is high. A woman with typical exertional angina, abnormal cardiac biomarkers, or concerning family history deserves complete evaluation even when initial tests are normal.

This is the standard of care in European guideline documents. American practice has been slower to adopt routine coronary reactivity testing, but the 2021 AHA/ACC Chest Pain Guideline acknowledges INOCA as a distinct clinical entity requiring specific diagnostic evaluation.

Matching the Test to the Question

Here is the clinical decision framework for cardiac imaging in women.

Clinical question: Does she have obstructive coronary artery disease? First-line test: CCTA (if pretest probability low to intermediate) or stress echocardiography (if pretest probability intermediate to high). Do not use: Treadmill ECG alone.

Clinical question: Is her chest pain due to inducible ischemia? First-line test: Stress echocardiography or stress CMR. Do not use: CCTA (shows anatomy, not function).

Clinical question: Are her coronary arteries normal after prior testing showed no obstruction? Next step: Stress CMR with perfusion imaging to assess microvascular function. Do not repeat: Another anatomical test.

Clinical question: Does she have coronary microvascular disease? Definitive test: Invasive coronary reactivity testing with acetylcholine provocation and coronary flow reserve measurement. Noninvasive surrogate: Stress CMR with quantitative perfusion reserve. For detailed guidance on cardiac MRI interpretation for women: cardiac MRI for women.

Clinical question: What is her coronary artery calcium burden for risk stratification? Test: Coronary artery calcium score CT. No contrast. Minimal radiation. Full guidance available: CAC score interpretation for women.

Clinical question: She had a heart attack with normal arteries. What happened? thorough evaluation: Cardiac MRI for tissue characterization plus invasive coronary reactivity testing. Complete clinical discussion: MINOCA heart attack in women.

The Cost of the Wrong Test

In 2019, the annual healthcare expenditure for cardiovascular disease in the United States exceeded $350 billion. A substantial fraction of this spending goes to repeat testing when initial evaluation is incomplete.

A woman receives a treadmill stress test. Negative. She returns with ongoing symptoms. She receives a nuclear stress test. Equivocal. She undergoes coronary angiography. Normal epicardial arteries. She is diagnosed with noncardiac chest pain and discharged.

Six months later, she presents with acute coronary syndrome. Her troponin is elevated. Her angiogram still shows nonobstructive disease. Now she receives a diagnosis: MINOCA. She is referred for cardiac MRI. It shows subendocardial infarction and impaired perfusion reserve.

The diagnosis could have been made months earlier with the right first test. The heart attack might have been prevented with appropriate therapy for microvascular disease.

The wrong test is not just a missed diagnosis. It is delayed treatment, accumulated myocardial injury, and increased lifetime cardiovascular risk.

What to Ask For at Your Next Appointment

At your next cardiology visit, bring this specific request.

If you need stress testing, ask for stress echocardiography or stress perfusion imaging, not treadmill ECG alone. Say: I understand that exercise ECG without imaging has limited accuracy in women. Can we use a test with imaging?

If your stress test was negative but symptoms continue, ask for cardiac MRI with adenosine stress perfusion. Say: I want to evaluate for microvascular disease. Standard stress testing does not assess small-vessel function.

If your angiogram showed normal coronary arteries but you had a troponin elevation or typical angina, ask for coronary reactivity testing. Say: I want to know if my symptoms are from coronary spasm or microvascular dysfunction. Can you perform acetylcholine provocation and flow reserve testing?

Print this article. Bring it to your appointment. Hand it to your cardiologist. The physicians who practice evidence-based medicine will recognize these recommendations from current guidelines. The ones who do not will benefit from the reminder.

Your symptoms are real. Your disease is real. The test should match the question.

Frequently Asked Questions

Why did my treadmill stress test come back normal if I still have chest pain?

Treadmill ECG relies on ST-segment changes during exercise to detect ischemia. In women, this approach has only 61% sensitivity, meaning nearly 4 in 10 women with coronary artery disease receive a false-negative result. The test cannot detect microvascular coronary disease at all, and this is the predominant form of ischemic heart disease in women. Additionally, hormonal effects on cardiac repolarization, single-vessel disease patterns, and lower peak exercise capacity all reduce diagnostic accuracy. A normal treadmill test does not prove your heart is healthy. It proves you need a different test.

Which stress test is most accurate for women?

Stress echocardiography provides 80% sensitivity and 86% specificity for detecting obstructive coronary disease in women, substantially outperforming treadmill ECG alone. For women with suspected microvascular disease, cardiac MRI with adenosine stress perfusion is the most accurate noninvasive test. It can measure myocardial perfusion reserve index and identify subendocardial ischemia that other modalities miss. Nuclear stress testing (SPECT MPI) has high sensitivity but lower specificity in women due to breast attenuation artifacts. PET myocardial perfusion imaging offers improved accuracy when available.

Should I get a coronary CT angiography instead of a stress test?

Coronary CT angiography answers a different question than stress testing. CCTA shows anatomy: whether you have plaque, stenosis, or blockages in your coronary arteries. It has 99% negative predictive value for excluding obstructive disease. However, CCTA cannot assess whether your coronary microcirculation is functioning normally. If your symptoms are from microvascular disease, your CCTA will appear normal even though disease is present. For women with low to intermediate pretest probability of obstructive disease, CCTA is excellent for ruling out blockages. For women with suspected microvascular disease, stress testing with imaging or cardiac MRI is more appropriate.

What is microvascular disease and why does it matter for imaging?

Microvascular coronary disease affects the small vessels, less than 500 micrometers in diameter, that standard angiography cannot visualize. These vessels regulate myocardial blood flow at the tissue level. When they are dysfunctional, the heart muscle does not receive adequate blood during exertion, causing angina and ischemia even when the large epicardial arteries are completely open. The WISE study demonstrated that women with microvascular dysfunction have 2.5 times higher cardiovascular event rates than asymptomatic controls. Only cardiac MRI with perfusion imaging or invasive coronary reactivity testing can diagnose this condition reliably. Standard stress echocardiography and CCTA miss it entirely.

How do I ask my doctor for the right test?

Be specific. Do not ask for a stress test. Ask for stress echocardiography or stress MRI with perfusion imaging. If your physician orders a treadmill ECG without imaging, ask why imaging is not being included given the reduced diagnostic accuracy in women. If your initial stress test was negative but symptoms persist, request referral for cardiac MRI with adenosine stress to evaluate for microvascular disease. If you had a troponin elevation with normal coronary arteries, request invasive coronary reactivity testing with acetylcholine provocation. Use the terminology from this article. Physicians respond to patients who understand the clinical questions being asked.